fbpx

Higher Serum Vitamin D levels Better for Colorectal Cancer

Share Button

These results suggest that higher 25OHD levels at surgery may be associated with a better survival rate of patients with colorectal cancer.

Numerous studies and articles posted on PeopleBeatingCancer cite vitamin D3 blood serum levels as both a predictor of cancer survival as well as a non-conventional therapy to manage cancer. The study linked and excerpted below suggests that vitamin D3 may be beneficial for colorectal cancer patients too.

This is another interesting article dealing with vitamin D levels and cancer, in this case, colorectal cancer and the levels of 250HD at the time of surgery.  I was interested in the fact that “serum 250HD levels were measured in 257 patients [and] only 3% had sufficient levels (30 ng/ml and greater).”  I hope much more vitamin D research will be conducted.

A large and growing number of studies point to supplementation as being an essential part of surviving cancer. I know that supplementation has been important to my own long-term survival.
Have you been diagnosed with colorectal cancer? Are you considering surgery? Please consider “prehabilitation” to prepare for your surgery.
thank you,
David Emerson 
  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Serum vitamin D levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study

BACKGROUND: Recently, serum 25-hydroxyvitamin D (25OHD) levels were shown to be associated with the survival of patients with colorectal cancer. However, 25OHD levels were measured a median of 6 years before diagnosis or were predicted levels. In this study, we directly measured serum 25OHD levels at surgery and examined the association with survival among patients with colorectal cancer.

RESULTS: Serum 25OHD levels were measured in 257 patients. Only 3% had sufficient levels (30 ng/ml and greater).

Conclusions These results suggest that higher 25OHD levels at surgery may be associated with a better survival rate of patients with colorectal cancer.

New study shows high vitamin D levels increase survival of patients with metastatic colorectal cancer

“According to a new study led by researchers at Dana-Farber Cancer Institute, clinical trial patients with metastatic colorectal cancer who had high levels of vitamin D in their bloodstream prior to treatment with chemotherapy and targeted drugs, survived longer, on average, than patients with lower levels of the vitamin…

The research, based on data from more than 1,000 patients with metastatic colorectal cancer who enrolled in a phase 3 clinical trial of chemotherapy plus biologic therapies, adds to vitamin D’s already impressive luster as a potential cancer-inhibiting agent. In the study, patients with the highest blood levels of vitamin D survived for a median period of 32.6 months, compared to 24.5 months for those with the lowest levels…”

Leave a Comment: